Oxford Immunotec Global PLC EBITDA Margin 2013-2020 | OXFD
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Oxford Immunotec Global PLC (OXFD) over the last 10 years. The current EBITDA margin for Oxford Immunotec Global PLC as of September 30, 2020 is .
| EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2020-09-30 | $0.06B | $-0.02B | -26.32% |
| 2020-06-30 | $0.06B | $-0.02B | -25.42% |
| 2020-03-31 | $0.07B | $-0.01B | -9.59% |
| 2019-12-31 | $0.07B | $-0.00B | -5.41% |
| 2019-09-30 | $0.07B | $-0.01B | -7.04% |
| 2019-06-30 | $0.07B | $-0.01B | -16.67% |
| 2019-03-31 | $0.06B | $-0.01B | -22.22% |
| 2018-12-31 | $0.06B | $-0.02B | -30.00% |
| 2018-09-30 | $0.04B | $-0.03B | -72.97% |
| 2018-06-30 | $0.04B | $-0.04B | -111.11% |
| 2018-03-31 | $0.05B | $-0.05B | -117.78% |
| 2017-12-31 | $0.06B | $-0.05B | -94.55% |
| 2017-09-30 | $0.05B | $-0.05B | -102.08% |
| 2017-06-30 | $0.06B | $-0.03B | -57.63% |
| 2017-03-31 | $0.05B | $-0.02B | -46.15% |
| 2016-12-31 | $0.05B | $-0.03B | -53.19% |
| 2016-09-30 | $0.08B | $-0.02B | -29.11% |
| 2016-06-30 | $0.07B | $-0.02B | -33.80% |
| 2016-03-31 | $0.07B | $-0.02B | -34.85% |
| 2015-12-31 | $0.06B | $-0.02B | -34.92% |
| 2015-09-30 | $0.06B | $-0.02B | -37.93% |
| 2015-06-30 | $0.05B | $-0.02B | -45.28% |
| 2015-03-31 | $0.05B | $-0.02B | -47.06% |
| 2014-12-31 | $0.05B | $-0.02B | -42.86% |
| 2014-09-30 | $0.05B | $-0.02B | -36.17% |
| 2014-06-30 | $0.05B | $-0.01B | -28.89% |
| 2014-03-31 | $0.04B | $-0.01B | -16.28% |
| 2013-12-31 | $0.04B | $-0.01B | -15.38% |
| 2013-09-30 | $0.04B | $-0.01B | -20.00% |
| 2013-06-30 | $0.03B | $-0.01B | -27.59% |
